152 related articles for article (PubMed ID: 9143459)
1. Parathyroid imaging with technetium-99m labelled cationic complexes: which tracer and which technique should be used?
Lind P
Eur J Nucl Med; 1997 Mar; 24(3):243-5. PubMed ID: 9143459
[No Abstract] [Full Text] [Related]
2. Radionuclide parathyroid imaging.
O'Doherty MJ
J Nucl Med; 1997 Jun; 38(6):840-1. PubMed ID: 9189126
[No Abstract] [Full Text] [Related]
3. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
4. Differences between technetium-99m tetrofosmin and technetium-99m sestamibi in parathyroid scintigraphy.
Giordano A; Meduri G
Eur J Nucl Med; 1997 Mar; 24(3):347. PubMed ID: 9143476
[No Abstract] [Full Text] [Related]
5. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
7. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of Tc-99m sestamibi and Tc-99m tetrofosmin in a case of parathyroid adenoma.
Mansi L; Rambaldi PF; Marino G; Pecori B; Del Vecchio E
Clin Nucl Med; 1996 Sep; 21(9):700-3. PubMed ID: 8879870
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m tetrofosmin. A new diagnostic tracer for parathyroid imaging.
Ishibashi M; Nishida H; Kumabe T; Morita S; Matoba F; Nomura G; Hayabuchi N
Clin Nucl Med; 1995 Oct; 20(10):902-5. PubMed ID: 8616997
[TBL] [Abstract][Full Text] [Related]
11. [Use of a gamma probe for intraoperative localization of parathyroid adenomas with Tc-99m-tetrofosmin and Tc-99m-sestamibi].
Gallowitsch HJ; Fellinger J; Kresnik E; Mikosch P; Pipam W; Unterweger OF; Lind P
Acta Med Austriaca; 1997; 24(2):73-8. PubMed ID: 9273810
[TBL] [Abstract][Full Text] [Related]
12. Delayed tc-99m sestamibi washout in graves' disease.
Balan KK; Baltrop AH; Wishart GC
Clin Nucl Med; 2003 Mar; 28(3):239-40. PubMed ID: 12592140
[No Abstract] [Full Text] [Related]
13. Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands.
Giordano A; Marozzi P; Meduri G; Ficola U; Calcagni ML; Vaccaro A; Rubini G; Attard M; Li Puma M; Ricci R; Corsello S
Eur J Nucl Med; 1999 Aug; 26(8):907-11. PubMed ID: 10436206
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
Leslie WD; Dupont JO; Bybel B; Riese KT
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
[TBL] [Abstract][Full Text] [Related]
17.
Huang Z; Lou C
J Int Med Res; 2019 Feb; 47(2):836-845. PubMed ID: 30556441
[TBL] [Abstract][Full Text] [Related]
18. Fusion imaging for parathyroid localization in primary hyperparathyroidism.
Levine DS; Wiseman SM
Expert Rev Anticancer Ther; 2010 Mar; 10(3):353-63. PubMed ID: 20214517
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
20. [Use of SPECT with (99m)Tc-Sestamibi in a patient affected by laryngeal carcinoma and parathyroid adenoma].
Giordano A; Galli J; Corina L; Samanes Gajate AM; D'Andrea G; Almadori G
Rev Esp Med Nucl; 2000 Jun; 19(3):211-4. PubMed ID: 11062085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
